Track topics on Twitter Track topics that are important to you
Vicus Capital increased its position in Bristol-Myers Squibb Company by 1.7% during the second quarter, according to its most recent 13F filing with the SEC. The fund owned 6,192 shares of the biopharmaceutical company's stock after buying an additional 106 shares during the period.
Original Article: Vicus Capital Buys 106 Shares of Bristol-Myers Squibb CompanyNEXT ARTICLE
The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...
Biopharmaceuticals are medical drugs produced using biotechnology. They include proteins (including antibodies), nucleic acids (DNA, RNA or antisense oligonucleotides) and living microorganisms like virus and bacteria where the virulance of viruses and b...